Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Molecular Cancer Therapeutics
|
November 4, 2018
Retraction: MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance By Targeting A20/NF-κB Signaling Pathway
Li-Na Li, Ta Xiao, Hong-Mei Yi, et al.
Molecular Cancer Therapeutics
|
July 13, 2017
MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway
Li-Na Li, Ta Xiao, Hong-Mei Yi, et al.
Cancer Letters
|
December 25, 2018
S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties
Jiao-Yang Li, Ta Xiao, Hong-Mei Yi, et al.
Clinical and Translational Medicine
|
November 30, 2020
Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma
Rong Shen, Peng-Peng Xu, Nan Wang, et al.
Cell Death & Disease
|
March 26, 2021
A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes
Ping Zhao, Meng-Meng Ji, Ying Fang, et al.
Cell Death & Disease
|
March 20, 2025
Retraction Note: Annexin A1-suppressed autophagy promotes nasopharyngeal carcinoma cell invasion and metastasis by PI3K/AKT signaling activation
Jin-Feng Zhu, Wei Huang, Hong-Mei Yi, et al.
Cell Death & Disease
|
November 22, 2018
Annexin A1-suppressed autophagy promotes nasopharyngeal carcinoma cell invasion and metastasis by PI3K/AKT signaling activation
Jin-Feng Zhu, Wei Huang, Hong-Mei Yi, et al.
Cell Death & Disease
|
June 2, 2017
MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway
Zhen Zheng, Jia-Quan Qu, Hong-Mei Yi, et al.
The Lancet. Healthy Longevity
|
September 14, 2022
Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study
Peng-Peng Xu, Zi-Yang Shi, Ying Qian, et al.
Plos One
|
February 6, 2014
Integrated analysis of differential miRNA and mRNA expression profiles in human radioresistant and radiosensitive nasopharyngeal carcinoma cells
Xin-Hui Li, Jia-Quan Qu, Hong Yi, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Molecular Cancer Therapeutics
|
November 4, 2018
Retraction: MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance By Targeting A20/NF-κB Signaling Pathway
Li-Na Li, Ta Xiao, Hong-Mei Yi, et al.
Molecular Cancer Therapeutics
|
July 13, 2017
MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway
Li-Na Li, Ta Xiao, Hong-Mei Yi, et al.
Cancer Letters
|
December 25, 2018
S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties
Jiao-Yang Li, Ta Xiao, Hong-Mei Yi, et al.
Clinical and Translational Medicine
|
November 30, 2020
Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma
Rong Shen, Peng-Peng Xu, Nan Wang, et al.
Cell Death & Disease
|
March 26, 2021
A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes
Ping Zhao, Meng-Meng Ji, Ying Fang, et al.
Cell Death & Disease
|
March 20, 2025
Retraction Note: Annexin A1-suppressed autophagy promotes nasopharyngeal carcinoma cell invasion and metastasis by PI3K/AKT signaling activation
Jin-Feng Zhu, Wei Huang, Hong-Mei Yi, et al.
Cell Death & Disease
|
November 22, 2018
Annexin A1-suppressed autophagy promotes nasopharyngeal carcinoma cell invasion and metastasis by PI3K/AKT signaling activation
Jin-Feng Zhu, Wei Huang, Hong-Mei Yi, et al.
Cell Death & Disease
|
June 2, 2017
MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway
Zhen Zheng, Jia-Quan Qu, Hong-Mei Yi, et al.
The Lancet. Healthy Longevity
|
September 14, 2022
Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study
Peng-Peng Xu, Zi-Yang Shi, Ying Qian, et al.
Plos One
|
February 6, 2014
Integrated analysis of differential miRNA and mRNA expression profiles in human radioresistant and radiosensitive nasopharyngeal carcinoma cells
Xin-Hui Li, Jia-Quan Qu, Hong Yi, et al.
Page
of 5